Pelvital, an Eagan, MN-based women’s health company, closed a $2.68m seed funding round.
The round was led by Boomerang Ventures, with participation from VisionTech Partners, Wisconsin Investment Partners, and Edward Bergmark, PhD, Founder and former CEO of Optum.
Led by Lydia Zeller, President and CEO, Pelvitan is advancing Flyte, an FDA-cleared treatment for stress urinary incontinence (SUI) and weakened pelvic floor muscles. It is an at-home intravaginal device that delivers the proven treatment modality of mechanotherapy to treat SUI and strengthen pelvic floor muscles quickly and effectively.
Flyte was originally developed by physicians from the Arctic University of Norway in collaboration with experts in gynecology, muscle rehabilitation and urinary incontinence treatments. Its mechanism of action is mechanotherapy, a foundational treatment modality that when paired with an active pelvic floor contraction stimulates tissue repair and the creation of neuromuscular memory.
The company intends to use the funds to complete development of its next generation product and to accelerate commercialization, expanding its reach to a broader audience of clinicians and women seeking an effective, conservative in-home treatment for stress urinary incontinence.
FinSMEs
01/08/2023